▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

Waltz Health Launches Waltz Connect to Lower Costs of Specialty Medications

Waltz Health, a digital health company developing smarter, technology-enabled ways to price, distribute and prescribe medications, today unveiled Waltz Connect, a new end-to-end solution that manages ...

Business Wire

New technology-powered, end-to-end solution gives payers more flexibility and optimizes savings with a network of specialty pharmacies that compete on price and clinical outcomes.

Reliance Rx joins Waltz Health’s pharmacy network, bringing better prices on generic specialty medications.

CHICAGO: Waltz Health, a digital health company developing smarter, technology-enabled ways to price, distribute and prescribe medications, today unveiled Waltz Connect, a new end-to-end solution that manages all aspects of a payer’s specialty medication coverage. It includes proprietary technology, patient engagement support, and a first-of-its-kind dynamic marketplace with a network of high-quality specialty pharmacies that compete on price, service levels, and clinical outcomes.

Waltz Connect empowers payers with unmatched transparency by unlocking competition among specialty pharmacies and is engineered to reduce specialty costs, improve member experience and deliver better member health outcomes. Its flexible design allows payers to deploy the solution across their entire specialty-drug formulary, on specific drug classes or even down to individual drugs. The solution is built on Waltz Health’s Intelligent Specialty Engine, which is an AI-enabled prescription routing software that intuitively finds the best and most-appropriate specialty pharmacy option based on specific criteria selected by each payer.

"Our novel approach layers on modern technology to bring transparency, efficiency and flexibility to specialty benefit management. For too long, the opaque and archaic structure of the traditional specialty drug supply chain has contributed to inefficiencies and misaligned incentives that have ballooned healthcare costs,” said Waltz Health Co-founder and CEO Mark Thierer. “When you bring marketplace principles to healthcare, you unlock competition on price and differentiation on experience. That’s no different in specialty drugs, which is why we’re offering a comprehensive solution that can be tailored to each payer’s unique needs and includes an entire network of specialty pharmacy partners committed to delivery savings and improved healthcare outcomes.”

The cost of specialty drugs has grown to more than $300 billion annually – up by more than 40% in just a few years – and now represents more than half of all spending on drugs in the U.S. Beyond just the high costs, the traditional process of filling specialty medications also has created frustrations for every stakeholder. Healthcare consumers often must wait weeks to get their medications; pharmacies receive prescriptions they are not able to fill; payers unnecessarily pay higher claims for the same drug; and everyone pays higher fees when another lower-cost pharmacy was an option.

Waltz Connect solves these issues by rewiring the process to make it more efficient and effective. When any specialty prescription for a member is submitted – regardless of the receiving pharmacy’s network status with the payer – the solution reroutes it to the best pharmacy option based on each member’s benefit design and a weighted list of attributes (price, turnaround time, fulfillment accuracy, members experience, adherence rates, and more). These attributes can be adjusted by drug class or specific drugs, ensuring members utilize the optimal fulfilling pharmacy with the least amount of friction.

Waltz Connect also captures all information payers need to ensure a consistent member experience including details on the member’s condition, prescription onboarding, contact details for the selected pharmacy, expected fulfillment turnaround time, number of refills and other important information. As a result, payers get more predictable pricing while their members experience less friction when filling their prescriptions.

In addition to launching Waltz Connect, Waltz Health also announced today that Reliance Rx has joined Waltz’s specialty network, providing payers with a high-performance, cost-efficient fulfillment option for generic specialty medications.

The launch of Waltz Connect marks another milestone for Waltz Health over the last year. Following its official entry into the payer, pharmacy benefit manager and self-insured employer markets, the company has launched unique deployments of its Marketplace Search technology with SCAN Health Plan and a national commercial health plan. The company also has unique versions of Marketplace Search in four national pharmacy chains with thousands of locations nationwide, generating savings on average of $5 to $10 more than other single-prescription drug-savings card solutions.

About Waltz Health

Waltz Health is a digital health company developing technologies and services that support better-informed decisions on prescription care. Designed for payers, pharmacies, pharmacy benefit managers and self-insured employers, the company offers AI-driven marketplaces to lower overall drug costs, providing better pricing options and more information for consumers while also helping payers take control of their pharmacy benefits. Founded in 2021 by Mark Thierer and Jonathon Thierer, Waltz Health is headquartered in Chicago and is backed by GV, Define Ventures, Echo Health Ventures, Blue Venture Fund, Byers Capital and Twine Ventures. For more information, visit www.waltzhealth.com.

About Reliance Rx

Reliance Rx is a specialty pharmacy offering national specialty pharmacy fulfillment and care coordination of complex disease states - resulting in greater efficiency, lower costs and improved services. Through enhanced communication between physicians, patients and its specialty pharmacy team, Reliance Rx aims to achieve maximum appropriate therapy adherence and promote positive clinical outcomes. Providing the best possible care drives everything they do, from a truly personalized experience to the effective delivery of specialty pharmacy services. https://www.reliancerxsp.com/.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

Keysight Launches All-In-One Solution for Network Visibility and Security

#AI--Keysight Technologies, Inc. (NYSE: KEYS) launched AppFusion, a network visibility partner program that integrates third-party security and monitoring…

AI Solutions for Visually Impaired, AI Search and AI Agents Win ISG Startup…

#AI--AI-powered solutions for addressing visual impairments, optimizing brands for AI search and creating AI agents won the ISG Startup Challenges at…

Sensormatic Solutions Extends Shrink Analyzer Capabilities ‘Beyond the…

Sensormatic Solutions, the leading global retail solutions portfolio of Johnson Controls (NYSE: JCI), continues its mission of building smarter, more…

N-Power Medicine Acquires Syapse to Expand Its Next-Generation Community-Based…

N-Power Medicine, a company leading the reinvention of the clinical trial process, today announced the acquisition of Syapse Holdings Inc. (“Syapse”),…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!